Advertisement

Topics

Bayer MaterialScience AG Company Profile

22:24 EDT 17th June 2018 | BioPortfolio

Bayer MaterialScience AG is an independent, globally operating company within the Bayer Group. The name Bayer MaterialScience stands for the materials that the company develops and produces. It also stands for the know-how and expertise of its employees all over the world, who register on average one new patent every working day. This spirit is embodied by the company’s mission statement "VisionWorks".

Location

Pitttsbutrg
Pennsylvania
United States of America

Contact

Phone: 10107773135
Fax: 14127773468
Email: hermann.bach@bayermaterialsscience.com


News Articles [823 Associated News Articles listed on BioPortfolio]

Bayer Divests More of Covestro

As it works toward unloading all of its shareholding in its former plastics subsidiary Covestro – the former Bayer MaterialScience – the Bayer group said it has begun an accelerated bookbu...

Covestro to Join Blue-chip Stock Index

Covestro, the former Bayer MaterialScience, will be elevated to the German index of blue-chip companies, DAX, from Mar. 19. The Leverkusen-based engineering plastics producer will replace media conglo...

Bayer bei Monsanto auf Zielgerade - Kapitalerhöhung

Die teuerste Übernahme eines deutschen Unternehmens im Ausland: Bayer schluckt Monsanto. Die Aktionäre müssen mithelfen. Bayer braucht Kapital. Wie sind da die Aussichten für die Bayer-Aktie, Vivi...

wikifolio whispers p.m. zu Evotec, WireCard, Bayer ...

Bayer -2.35% Tiedemann (TIEDE001): Kauf einer Aktie zu 100,059 € --- Bilanz -48,634 € (28.05. 15:10) >> mehr comments zu Bayer: www.boerse-social.com/launch/aktie/bayer_ag Bayer -2.35% Tiedemann (...

UPDATE/China genehmigt Bayer Monsanto-Übernahme unter Auflagen

--Bayer muss sich von Saatgütern trennen --China fordert Zugang zu Digital-Farming-Plattformen --Bayer sieht Auflagen mit BASF-Verkaufsplänen als erfüllt (NEU: Stellungnahme von Bayer) Von Olaf Ri....

Bayer shareholder Temasek to boost share capital

Bayer AG said late Monday that investment company Temasek has signed an agreement to increase its share capital in the German company. Temasek has subscribed to 31 million new Bayer shares, which equa...

Bayer stock: Interesting dividend?

During the last week, Robert Sasse took a closer look at Bayer. This is his conclusion: Ever since 2006 the Bayer shareholders received rising dividends. There was only one exception. Only in 2009 ...

Bayer: Neues Kursziel nach der US-Nachricht

Die Analysten der UBS überarbeiten ihr Modell für die Aktien von Bayer. Wie bisher gibt es für die Papiere von Bayer eine Kaufempfehlung. Das Kursziel für die Bayer-Aktien sahen die Experten bishe...

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Interrupted Bayer-Villiger Rearrangement: Building A Stereoelectronic Trap for the Criegee Intermediate.

The instability of hydroxyl peroxyesters, the elusive Criegee intermediates of the Bayer-Villiger rearrangement, can be alleviated by selective deactivation of stereoelectronic effects that promote th...

Surgical Management After Hysteroscopic Sterilization: Minimally Invasive Approach Incorporating Intraoperative Fluoroscopy for Symptomatic Patients with >2 Essure® Devices.

To describe a non-hysterectomy surgical technique for symptomatic patients with >2 Essure® (Bayer Healthcare, Whippany, New Jersey) devices.

Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study.

Progestin therapy has been accepted as therapy for low- and medium-risk endometrial hyperplasia. The aim of this study was to investigate the efficacy of the low-dose levonorgestrel-impregnated intrau...

10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016.

The aim of this study was to critically assess the evaluation and categorization process for nephrogenic systemic fibrosis (NSF) based on reports received by Bayer from 2006 to 2016.

Metformin for endometrial hyperplasia.

Endometrial cancer is one of the most common gynaecological cancers in the world. Rates of endometrial cancer are rising, in part because of rising obesity rates. Endometrial hyperplasia is a precance...

Clinical Trials [33 Associated Clinical Trials listed on BioPortfolio]

International PMS Study - KOGENATE Bayer

To evaluate long-term safety (primarily by recording adverse events including inhibitors), efficacy and patient acceptance of KOGENATE Bayer in home treatment either on prophylaxis or on d...

EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS

The aim of this international prospective, non-interventional post-marketing surveillance study is to obtain data on treatment procedures, long-term safety and efficacy and patient accepta...

Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-t

This study aims is to evaluate, two hours after a single administration, the rate of sustained response produced by the association Geolab consisting of acetylsalicylic acid, sodium bicarb...

A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-Fasting Conditions

The purpose of this study is compare the relative bioavailability of Nifedipine ER tablets 60 mg by Abrica Pharmaceuticals LLLP with that of ADALAT® CC Extended Release Tablets 60 mg by ...

Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions

The present study will be performed to investigate and to compare the in-vivo performance of the two investigational products Gen-nifedipine extended release, (previously referred to as Ge...

Companies [57 Associated Companies listed on BioPortfolio]

Bayer MaterialScience AG

Bayer MaterialScience AG is an independent, globally operating company within the Bayer Group. The name Bayer MaterialScience stands for the materials that the company develops and produces. It also s...

Bayer USA Foundation

The Bayer USA Foundation is an endowed 501(c)(3) entity and is the primary source of Bayer Corporation’s philanthropy in the United States. With a programmatic focus on the e...

Bayer Diabetes Care

Bayer Diabetes Care is a worldwide leader in diabetes care, supporting customers in 100 countries and, for more than 40 years, has led the way in diabetes care product innovation. Today, Bayer Diabete...

Bayer CropScience LP

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience AG, a subsidiary of Bayer AG with annual sales of about EUR 6.4 b...

Bayer Corporation

Bayer AG is the first company in the world to forge a long-term partnership with UNEP in the area of youth and environment. The partners first began cooperating on youth environme...

More Information about "Bayer MaterialScience AG" on BioPortfolio

We have published hundreds of Bayer MaterialScience AG news stories on BioPortfolio along with dozens of Bayer MaterialScience AG Clinical Trials and PubMed Articles about Bayer MaterialScience AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bayer MaterialScience AG Companies in our database. You can also find out about relevant Bayer MaterialScience AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record